Natural Products from Marine Fungi for the treatment of cancer


 

The MarineFungi consortium demonstrated the sustainable exploitation of marine natural resources providing appropriate culture conditions. New anti cancer compounds are now  characterised to the stage of in vivo proof of concept ready to enter further drug development. Read more about our approach and background by choosing the approriate section in the pull down menue on top of the page.

We developed the technological basis for a sustainable use of marine microbial products along the added-value chain from the marine habitat to the drug candidate and process concept. Find our publications.

The project MARINE FUNGI was from May 2011-April 2014. The consortium continues the work and will use this site to share results and insights and the development of marine biotechnology. See our partners in the PARTNER menue.

Download our report.

Follow us on

 

newsticker

Genome of Scopulariopsis brevicaulis

The MARINE FUNGI Consortium was able to sequence the genome of Scopulariopsis brevicaulis using three different next generation sequencing methods in good and reliable quality. The assembly and annotation of the sequences is ongoing.

Blue Biotech Cooperation Event

Blue Biotech Cooperation Event: New strategies and future perspectives

Within the scope of the SUBMARINER project, the Center for Marine Natural Products (KiWiZ) at IFM-GEOMAR and Norgenta North German Life Science Agency GmbH will host the Blue Biotechnology Cooperation Event “New Strategies and Future Perspectives”. It will take place in Kiel, Germany on May 9th and 10th, 2012.

read more...

MARINE FUNGI website setup started

comments welcome, please contact Beate

Zeige 76 - 78 von 79 Ergebnissen.
Elemente pro Seite 3
von 27